US Patent 7399868 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists

Patent 7399868 was granted and assigned to Allergan, Inc. on July, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Allergan, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73998680

Patent Inventor Names

Ken Chow0

Michael E. Garst0

Larry A. Wheeler0

Todd M. Heidelbaugh0

Phong X. Nguyen0

Daniel W. Gil0

John E. Donello0

Date of Patent

July 15, 2008

Patent Application Number

112323230

Date Filed

September 20, 2005

Patent Primary Examiner

‌

Joseph McKane

Patent abstract

Compounds of Formula 1

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7399868 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API